samedan logo
 
 
spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Clinical Trial Supply Europe 2019

Arena - Clinical Trial Supply Europe 2019

13-14 March 2019
Milan, Italy

Following on from our largest and most engaging meeting to date, Clinical Trial Supply Europe will be returning to Milan for its 20th year in 2019!

The 19th annual edition welcomed pharmaceutical companies across Europe who got together to share knowledge and issues regarding clinical trial supplies, both with regards to operational and technological challenges. Over the two days, delegates discussed issues which affected their business in our dedicated operational and technological streams.

With over 21 different companies showcasing their latest case studies and developments our 19th edition truly was a highlight in the industry’s calendar. Clinical Trial Supply Europe remains an industry leader in showcasing what steps industry is taking to improve clinical supplies for patients. Throughout the two days, delegates enjoyed a dynamic programme of case-study presentations, interactive panel discussions and networking breaks which enabled the audience to discover practical takeaways and local knowledge sharing.

A huge thank you to all the industry leading speakers and vendors who provided insightful perspectives and key thought leadership over the two day conference. We look forward to seeing you all next year back in Milan for another great couple of days where you can learn, discuss and meet clinical trial supply leaders across Europe.

Call to action: the 2019 programme for the 20th Anniversary edition is currently underway. Contact Arena International if you have an interesting topic proposal to showcase at Europe’s flagship Clinical Trial Supply event.

phone +44 (0)207 936 6400
email events@arena-international.com
web www.arena-international.com/ctseurope/
email Milan, Italy
 
Print this page
Send to a friend
   
spacer
Industry Events

PDA Parenteral Packaging 2019

19-20 March 2019, Hilton Molino Stucky, Venice, Italy

PDA Europe’s Conference has become a must-attend event for all professionals in the Parenteral Packaging arena. Join us in Venice in March 2019 to continue and further deepen scientific advancements and our ongoing professional discourse of latest on primary packaging technologies and business trends. This conference and the accompanying exhibition address quality of components and cont­ainers, container closure development and integrity testing as well as aspects of processing, product distribution and storage.
More info >>

Banner of DIA_Europe_Events_95 on Samedan Banner of Drug Delivery Partnership 2018_events_97 on Samedan Banner of PHPL West Coast_events_95 on Samedan

White Papers

How To Increase Efficiency, Customer Satisfaction and Reduce Cost

AC Labels

A customer of Riverside Medical had required a complex four-part 'piggy back' label. The labels needed to be specially constructed to facilitate removal in parts at various stages of its use for quality control traceability. This label needed to carry variable data elements of LOT numbers, batch numbers and product descriptions, and also a secondary gamma indicator label placed on each of its 4 sections to prove its sterility following sterilisation.
More info >>


News and Press Releases

Datwyler celebrates official opening of its new production plant with First Line standard in Middletown, Del

• The new facility in Middletown, Del., is Datwyler’s third facility with First Line standard which will be catering to the markets in North and South America • Approximately 120 jobs will be created, with the majority staffed from the local community • With the Middletown facility, Datwyler will be able to increase its global First Line production by 50 percent by 2020 • First Line is specially designed to manufacture biotech and pharmaceutical elastomer components in a fully integrated good manufacturing practice (GMP) environment
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement